Infections After Receipt of Bacterially Contaminated Umbilical Cord Blood–Derived Stem Cell Products for Other Than Hematopoietic or Immunologic Reconstitution — United States, 2018

December 26, 2018 at 8:52 am

Morbidity and Mortality Weekly Report December 21, 2018  V.67 N.50 P.1397–1399

Infections After Receipt of Bacterially Contaminated Umbilical Cord Blood–Derived Stem Cell Products for Other Than Hematopoietic or Immunologic Reconstitution — United States, 2018

The only Food and Drug Administration (FDA)–approved stem cell products are derived from umbilical cord blood, and their only approved use is hematopoietic and immunologic reconstitution (1).

On September 17, 2018, the Texas Department of State Health Services received notification of Enterobacter cloacae and Citrobacter freundii bloodstream infections in three patients who had received injections or infusions of non-FDA–approved umbilical cord blood-derived stem cell products processed by Genetech, Inc., and distributed by Liveyon, LLC, for other than hematopoietic or immunologic reconstitution at an outpatient clinic on September 12.

Patient isolates of E. cloacae had identical pulsed-field gel electrophoresis patterns, suggesting a common source …

PDF

https://www.cdc.gov/mmwr/volumes/67/wr/pdfs/mm6750a5-H.pdf

Entry filed under: Antimicrobianos, Bacterias, Bacteriemias, Epidemiología, FIEBRE en el POSTOPERATORIO, Health Care-Associated Infections, Infecciones en neutropenicos, Infecciones en onco-hematologicos, Infecciones nosocomiales, Metodos diagnosticos, REPORTS, Sepsis, Update.

Hantavirus pulmonary syndrome in Buenos Aires, 2009-2014. Deadly Marburg Virus Found in Sierra Leone Bats


Calendar

December 2018
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Most Recent Posts


%d bloggers like this: